Package 61958-2901-2

{"route": ["INTRAVENOUS"], "spl_id": "2399f66f-aacb-4743-8117-b722c91b4bac", "openfda": {"nui": ["N0000193948"], "unii": ["3QKI37EEHE"], "rxcui": ["2284960", "2367758", "2395502", "2395504"], "spl_set_id": ["c0978fa8-53ff-4ca2-82a7-567fd3e958ca"], "pharm_class_epc": ["SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]"], "manufacturer_name": ["Gilead Sciences, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61958-2901-2)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE", "package_ndc": "61958-2901-2", "marketing_start_date": "20201101"}], "brand_name": "Veklury", "product_id": "61958-2901_2399f66f-aacb-4743-8117-b722c91b4bac", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]"], "product_ndc": "61958-2901", "generic_name": "remdesivir", "labeler_name": "Gilead Sciences, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Veklury", "active_ingredients": [{"name": "REMDESIVIR", "strength": "100 mg/1"}], "application_number": "NDA214787", "marketing_category": "NDA", "marketing_start_date": "20201101", "listing_expiration_date": "20271231"}